Tata Medical and Diagnostics, the healthcare unit of India's Tata Group, launched its Covid-19 test kit which will be made available at laboratories and hospitals from December, its CEO Girish Krishnamurthy told Reuters.

The government-approved test, which can provide the final result within 90 minutes, will be manufactured at Tata's plant in Chennai in southern India which has the capacity to produce 1 million test kits a month, Krishnamurthy said.

The launch comes as India's Covid-19 cases rose by 45,903 to 8.55 million with deaths rising by 490 to 126,611, government data showed.

Opinion

Editorial

Budget presser
Updated 14 Jun, 2026

Budget presser

If the FBR falters, the government will find itself in hot water sooner rather than later.
Muharram precautions
14 Jun, 2026

Muharram precautions

WITH Muharram due to start next week, the authorities have already begun annual exercises to ensure that the ...
Blood bequests
14 Jun, 2026

Blood bequests

WORLD Blood Donor Day offers a moment of “gratitude, advocacy and renewed commitment” for thalassaemia patients...
Sustainable path?
Updated 13 Jun, 2026

Sustainable path?

The FY27 budget is the first clear signal that the government is ready to transition from stabilisation to growth.
Prioritising education
13 Jun, 2026

Prioritising education

THOUGH the improvement in the country’s literacy rate may be slight, as highlighted by the Economic Survey, it ...
Poverty’s rise
13 Jun, 2026

Poverty’s rise

AS attention turns to the government’s plans for the coming fiscal year, one set of figures deserves particular...